Ipca Laboratories Limited

BSE: 524494 NSE: IPCALAB
Ipca Laboratories Limited - pharma in Kandivali West, Maharashtra, India. FY 2026 financials and compliance.
CIN L24239MH1949PLC007837 Incorporated 19 October 1949 ROC Mumbai HQ Kandivali West, Maharashtra, India
Active Listed - NSE: IPCALAB · BSE: 524494 Public Limited Company pharma
Data last updated
Revenue · FY 2026
₹9,646.33 Cr
▲ 7.91% YoY
Computed EBITDA · FY 2026
₹2,153.01 Cr
▲ 18.37% YoY
Net profit · FY 2026
₹1,183.78 Cr
▲ 50.75% YoY
Authorised capital
₹57.6 Cr
Registered with MCA
Paid-up capital
₹25.37 Cr
Issued & subscribed
Open charges
₹2,303.63 Cr
Satisfied ₹2,406.67 Cr
Company age
77 yrs
Est. 1949
Employees · EPFO
17,422
Latest available

About Ipca Laboratories Limited

Data last updated: 14 July 2026

Ipca Laboratories Limited is a public limited company based in Kandivali West, Maharashtra, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 19 October 1949, the company has been in operation for over 77 years.

Registered with ROC Mumbai under CIN L24239MH1949PLC007837. Listed on BSE: 524494 and NSE: IPCALAB.

Capital: an authorised share capital of ₹57.6 Cr and a paid-up capital of ₹25.37 Cr. Formerly known as The Indian Pharmaceutical Combine Association Ltd. It is led by directors including Narendra Mairpady and Ajit Kumar Jain.

Last AGM: 11 August 2025. Financial statements filed for year ended 31 March 2025. Office: Kandivali West, Maharashtra.

As per NSE-filed consolidated financials for FY 2026, the company reported a revenue of ₹9,646.33 Cr, a growth of 7.91% compared to the previous year. The net worth stands at ₹9,524.06 Cr (up 13.54% YoY). Total assets are valued at ₹12,370 Cr (up 5.18% YoY).

The company has a workforce of approximately 17,422 employees as per the latest available data. Its group structure includes 3 subsidiaries and 2 joint ventures.

The company is associated with 2 brands - Ipca Laboratories, Ipca Laboratories. As per MCA filings, the company has open charges of ₹2,303.63 Cr and satisfied charges of ₹2,406.67 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ipca.com.

Company Details of Ipca Laboratories Limited
CIN L24239MH1949PLC007837
Registration Number 007837
Incorporation Date 19 October 1949
ROC Mumbai
Listing Status Listed (BSE: 524494, NSE: IPCALAB)
Company Status Active
Date of Last AGM 11 August 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Ajit Kumar Jain Managing Director Pranay Premchand Godha Managing Director Premchand Gigalal Godha Whole-Time Director
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    ipca.com
  • Social Media
  • Registered Address
    48 Kandivli Industrial Estate, Kandivli (West), Kandivali West, Maharashtra, India – 400067
  • Industry
    Pharma, Drug Formulation & Development, API Manufacturers
Company report
Ipca Laboratories Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Ipca Laboratories Limited report

Financials, compliance, directors, charges, ownership and filings for Ipca Laboratories Limited in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Ipca Laboratories Limited

Ipca Laboratories Limited operates two associated brands: Ipca Laboratories and Ipca Laboratories. These brands represent Ipca Laboratories Limited's diversified market presence and brand portfolio.

Brand Description Website
Ipca Laboratories
APIs and drug formulations are manufactured for therapeutic segments. ipca.com
Ipca Laboratories
Ipca Laboratories is engaged in pharmaceutical manufacturing and distribution. ipcalabs.com

Business Activity of Ipca Laboratories Limited

Ipca Laboratories Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Ipca Laboratories Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Ipca Laboratories Limited

Ipca Laboratories Limited is audited by NVC & Associates LLp (ICAI peer reviewed, certificate valid till 2027-07-31) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
NVC & Associates LLp (ICAI peer reviewed, certificate valid till 2027-07-31) FY 2026 Declaration of unmodified opinion

Board of Directors of Ipca Laboratories Limited

Ipca Laboratories Limited is currently managed by 8 directors, with 11 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Narendra Mairpady
Also directs: Kesar Enterprises Limited, Saatvik Green Energy Limited, Equippp Social Impact Technologies Limited and 5 more
Director 20 Oct 2022 3 Years 9 Months Current
Ajit Kumar Jain
Also directs: Ipca Foundation
Managing Director 21 Aug 2009 16 Years 11 Months Current
Kamal Kishore Seth
Also directs: Ipca Foundation, Gufic Biosciences Limited, Indo-Vietnamese Chamber Of Commerce And Industry
Director 29 Mar 2019 7 Years 4 Months Current
Pranay Premchand Godha
Also directs: Xgrow Traders Llp, Kaygee Laboratories Private Limited, Kaygee Investments Private Limited and 2 more
Managing Director 30 Jul 2009 17 Years 0 Months Current
Premchand Gigalal Godha
Also directs: Ipca Foundation, Xgrow Traders Llp, Kaygee Laboratories Private Limited and 1 more
Whole-Time Director 31 Jan 2012 14 Years 6 Months Current
Prashant Godha
Also directs: Ipca Foundation, Xgrow Traders Llp, Kaygee Laboratories Private Limited and 5 more
Director 28 Jul 2011 15 Years 0 Months Current
Showing 6 of 8 current directors. View all directors

Financials of Ipca Laboratories Limited FY 2026 filings available

Ipca Laboratories Limited reported revenue of ₹9,646.33 Cr (up 7.91% YoY) for FY 2026.

Revenue · FY 2026
₹9,646.33 Cr ▲ 7.91%
Profit · FY 2026
₹1,183.78 Cr ▲ 50.75%
Computed EBITDA · FY 2026
₹2,153.01 Cr ▲ 18.37%
Revenue₹ Cr · Consolidated05,00010,000FY 2020: ₹4,649 Cr4,649FY 2020FY 2021: ₹5,420 Cr · +16.6% YoY5,420+16.6%FY 2021FY 2022: ₹5,830 Cr · +7.6% YoY5,830+7.6%FY 2022FY 2023: ₹6,244 Cr · +7.1% YoY6,244+7.1%FY 2023FY 2024: ₹7,705 Cr · +23.4% YoY7,705+23.4%FY 2024FY 2025: ₹8,940 Cr · +16% YoY8,940+16%FY 2025FY 2026: ₹9,646 Cr · +7.9% YoY9,646+7.9%FY 2026
Net Profit₹ Cr · Consolidated05001,0001,500FY 2020: ₹604 Cr604FY 2020FY 2021: ₹1,141 Cr · +89.1% YoY1,141+89.1%FY 2021FY 2022: ₹890 Cr · -22% YoY890-22%FY 2022FY 2023: ₹479 Cr · -46.2% YoY479-46.2%FY 2023FY 2024: ₹523 Cr · +9.2% YoY523+9.2%FY 2024FY 2025: ₹785 Cr · +50.2% YoY785+50.2%FY 2025FY 2026: ₹1,184 Cr · +50.8% YoY1,184+50.8%FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year01,0002,0003,000Q1'25: ₹2,093 Cr · +31.8% YoY2,093+31.8%Q1'25Q2'25: ₹2,355 Cr · +15.8% YoY2,355+15.8%Q2'25Q3'25: ₹2,245 Cr · +9.4% YoY2,245+9.4%Q3'25Q4'25: ₹2,247 Cr · +10.5% YoY2,247+10.5%Q4'25Q1'26: ₹2,309 Cr · +10.3% YoY2,309+10.3%Q1'26Q2'26: ₹2,557 Cr · +8.6% YoY2,556+8.6%Q2'26Q3'26: ₹2,393 Cr · +6.6% YoY2,392+6.6%Q3'26Q4'26: ₹2,388 Cr · +6.3% YoY2,388+6.3%Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue from Operations ₹9,646.33 Cr ₹8,939.59 Cr ₹7,705.04 Cr ₹6,244.32 Cr ₹5,829.79 Cr ₹5,419.99 Cr ₹4,648.71 Cr
Other Income ₹174.45 Cr ₹92.8 Cr ₹124.77 Cr ₹125.62 Cr ₹66.57 Cr ₹62.84 Cr ₹67 Cr
Total Income ₹9,820.78 Cr ₹9,032.39 Cr ₹7,829.81 Cr ₹6,369.94 Cr ₹5,896.36 Cr ₹5,482.83 Cr ₹4,715.71 Cr
Cost of Materials Consumed ₹2,344.01 Cr ₹2,276.82 Cr ₹2,216.32 Cr ₹1,708.65 Cr ₹1,664.2 Cr ₹1,597.14 Cr ₹1,460.37 Cr
Purchases of Stock-in-Trade ₹532.62 Cr ₹547.78 Cr ₹490.07 Cr ₹497.19 Cr ₹480.3 Cr ₹325.95 Cr ₹359.88 Cr
Changes in Inventories -₹53.91 Cr -₹46.05 Cr -₹130.64 Cr ₹100.67 Cr -₹129.65 Cr -₹194.79 Cr -₹176.12 Cr
Employee Benefit Expense ₹2,160.2 Cr ₹1,983.99 Cr ₹1,708.43 Cr ₹1,287.64 Cr ₹1,177.39 Cr ₹1,013.57 Cr ₹921.23 Cr
Finance Costs ₹75.94 Cr ₹84.93 Cr ₹138.27 Cr ₹45.54 Cr ₹7.69 Cr ₹9.04 Cr ₹16.5 Cr
Depreciation & Amortisation ₹418.12 Cr ₹397.82 Cr ₹357.24 Cr ₹261.56 Cr ₹232.42 Cr ₹209.17 Cr ₹210.5 Cr
Other Expenses ₹2,684.85 Cr ₹2,450.91 Cr ₹2,099.7 Cr ₹1,723.4 Cr ₹1,328.29 Cr ₹1,133.77 Cr ₹1,176.65 Cr
Total Expenses ₹8,161.83 Cr ₹7,696.2 Cr ₹6,879.39 Cr ₹5,624.65 Cr ₹4,760.64 Cr ₹4,093.85 Cr ₹3,969.01 Cr
Profit Before Exceptional Items & Tax ₹1,658.95 Cr ₹1,336.19 Cr ₹950.42 Cr ₹745.29 Cr ₹1,135.72 Cr ₹1,388.98 Cr ₹746.7 Cr
Exceptional Items -₹86.43 Cr -₹205.05 Cr -₹107.75 Cr ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹1,572.52 Cr ₹1,131.14 Cr ₹842.67 Cr ₹745.29 Cr ₹1,135.72 Cr ₹1,388.98 Cr ₹746.7 Cr
Total Tax Expense ₹381.15 Cr ₹343.61 Cr ₹313.46 Cr ₹253.36 Cr ₹224.27 Cr ₹240.14 Cr ₹135.33 Cr
Net Profit ₹1,183.78 Cr ₹785.24 Cr ₹522.92 Cr ₹478.99 Cr ₹889.79 Cr ₹1,141.14 Cr ₹603.56 Cr
  attributable to Owners ₹1,141.12 Cr ₹737.68 Cr ₹547.35 Cr ₹471.32 Cr ₹884.08 Cr ₹1,140.01 Cr ₹606.32 Cr
  attributable to NCI ₹42.66 Cr ₹47.56 Cr -₹24.43 Cr ₹7.67 Cr ₹5.71 Cr ₹1.13 Cr -₹2.76 Cr
Other Comprehensive Income ₹42.76 Cr -₹24.55 Cr -₹9.45 Cr ₹7.34 Cr ₹3 Cr -₹40 Lakh ₹3.53 Cr
Total Comprehensive Income ₹1,226.54 Cr ₹760.69 Cr ₹513.47 Cr ₹486.33 Cr ₹892.79 Cr ₹1,140.74 Cr ₹607.09 Cr
EBITDA (computed) ₹2,153.01 Cr ₹1,818.94 Cr ₹1,445.93 Cr ₹1,052.39 Cr ₹1,375.83 Cr ₹1,607.19 Cr ₹973.7 Cr
Basic EPS ₹44.98 ₹29.08 ₹21.57 ₹18.58 ₹34.85 ₹90.11 ₹47.77
Diluted EPS ₹44.98 ₹29.08 ₹21.57 ₹18.58 ₹34.85 ₹90.11 ₹47.73
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹12,370 Cr ₹11,761 Cr ₹11,101 Cr ₹8,626.43 Cr
Non-current Assets ₹5,993.33 Cr ₹5,492.01 Cr ₹5,562.38 Cr ₹3,437.16 Cr
Current Assets ₹6,373.61 Cr ₹5,967.04 Cr ₹5,535.55 Cr ₹5,189.27 Cr
Property, Plant & Equipment ₹4,440.59 Cr ₹4,068.91 Cr ₹4,339.51 Cr ₹2,572.41 Cr
Inventories ₹2,731 Cr ₹2,560.42 Cr ₹2,471.31 Cr ₹1,743.37 Cr
Trade Receivables ₹2,014.26 Cr ₹1,873.82 Cr ₹1,686.51 Cr ₹989.02 Cr
Cash & Equivalents ₹437.12 Cr ₹167.17 Cr ₹208.91 Cr ₹1,257.85 Cr
Equity (Net Worth) ₹9,524.06 Cr ₹8,388.27 Cr ₹7,727 Cr ₹5,915.32 Cr
Equity Share Capital ₹25.37 Cr ₹25.37 Cr ₹25.37 Cr ₹25.37 Cr
Borrowings (Non-current) ₹109.12 Cr ₹543.24 Cr ₹580.41 Cr ₹651.78 Cr
Borrowings (Current) ₹594.82 Cr ₹758.46 Cr ₹807.09 Cr ₹805.75 Cr
Total Debt (computed) ₹703.94 Cr ₹1,301.7 Cr ₹1,387.5 Cr ₹1,457.53 Cr
Current Liabilities ₹2,306.93 Cr ₹2,384.29 Cr ₹2,355.64 Cr ₹1,805.82 Cr
Total Liabilities ₹2,846.13 Cr ₹3,372.28 Cr ₹3,374.28 Cr ₹2,711.11 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹1,141.97 Cr ₹1,321.32 Cr ₹944.65 Cr ₹805.81 Cr ₹856.04 Cr
Investing Cash Flow -₹246.77 Cr -₹869.5 Cr -₹1,291.79 Cr -₹725 Cr -₹855.05 Cr
Financing Cash Flow -₹753.53 Cr -₹282.98 Cr -₹552.55 Cr ₹507.24 Cr ₹426.81 Cr
Capital Expenditure ₹652.26 Cr ₹775.52 Cr ₹411.29 Cr ₹494.47 Cr ₹478.95 Cr
Free Cash Flow (computed) ₹489.71 Cr ₹545.8 Cr ₹533.36 Cr ₹311.34 Cr ₹377.09 Cr
Dividends Paid ₹52.41 Cr ₹101.48 Cr ₹50.74 Cr ₹101.48 Cr ₹101.45 Cr
Net Change in Cash ₹141.67 Cr ₹168.84 Cr -₹899.69 Cr ₹588.05 Cr ₹427.8 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹2,388.48 Cr ₹2,392.5 Cr ₹2,556.5 Cr ₹2,308.85 Cr ₹2,246.69 Cr ₹2,245.37 Cr ₹2,354.9 Cr ₹2,092.63 Cr ₹2,033.01 Cr ₹2,052.86 Cr ₹2,033.96 Cr ₹1,587.58 Cr
Other Income ₹93.74 Cr ₹20.19 Cr ₹27.86 Cr ₹32.66 Cr ₹25.82 Cr ₹20.11 Cr ₹26.26 Cr ₹20.61 Cr ₹18.92 Cr ₹22.45 Cr ₹38.55 Cr ₹44.85 Cr
Total Income ₹2,482.22 Cr ₹2,412.69 Cr ₹2,584.36 Cr ₹2,341.51 Cr ₹2,272.51 Cr ₹2,265.48 Cr ₹2,381.16 Cr ₹2,113.24 Cr ₹2,051.93 Cr ₹2,075.31 Cr ₹2,072.51 Cr ₹1,632.43 Cr
Cost of Materials Consumed ₹592.6 Cr ₹564.44 Cr ₹569.87 Cr ₹617.1 Cr ₹660.07 Cr ₹482.44 Cr ₹588.99 Cr ₹545.32 Cr ₹565.05 Cr ₹609.95 Cr ₹608.9 Cr ₹432.42 Cr
Purchases of Stock-in-Trade ₹149.22 Cr ₹129.83 Cr ₹126.83 Cr ₹126.74 Cr ₹86.98 Cr ₹188.29 Cr ₹153.83 Cr ₹118.68 Cr ₹108.57 Cr ₹116.32 Cr ₹144.09 Cr ₹121.09 Cr
Changes in Inventories -₹50.2 Cr -₹36.37 Cr ₹84.94 Cr -₹52.28 Cr -₹38.76 Cr -₹2.52 Cr ₹15.74 Cr -₹20.51 Cr ₹12.27 Cr -₹29.32 Cr -₹75.41 Cr -₹38.18 Cr
Employee Benefit Expense ₹533 Cr ₹546.09 Cr ₹537.94 Cr ₹543.17 Cr ₹500.84 Cr ₹485.44 Cr ₹509.84 Cr ₹487.87 Cr ₹466.01 Cr ₹459.04 Cr ₹425.87 Cr ₹357.51 Cr
Finance Costs ₹20.2 Cr ₹17.62 Cr ₹19.61 Cr ₹18.51 Cr ₹21.51 Cr ₹16.81 Cr ₹22.56 Cr ₹24.05 Cr ₹29.37 Cr ₹33.4 Cr ₹44.12 Cr ₹31.38 Cr
Depreciation & Amortisation ₹107.14 Cr ₹107.59 Cr ₹103.33 Cr ₹100.06 Cr ₹100.12 Cr ₹98.46 Cr ₹100.35 Cr ₹98.89 Cr ₹98.13 Cr ₹99.5 Cr ₹90.34 Cr ₹69.27 Cr
Other Expenses ₹679.99 Cr ₹655.16 Cr ₹692 Cr ₹657.7 Cr ₹608.7 Cr ₹628.64 Cr ₹645.02 Cr ₹568.55 Cr ₹559.21 Cr ₹565.54 Cr ₹609.24 Cr ₹407.12 Cr
Total Expenses ₹2,031.95 Cr ₹1,984.36 Cr ₹2,134.52 Cr ₹2,011 Cr ₹1,939.46 Cr ₹1,897.56 Cr ₹2,036.33 Cr ₹1,822.85 Cr ₹1,838.61 Cr ₹1,854.43 Cr ₹1,847.15 Cr ₹1,380.61 Cr
Profit Before Exceptional Items & Tax ₹450.27 Cr ₹428.33 Cr ₹449.84 Cr ₹330.51 Cr ₹333.05 Cr ₹367.92 Cr ₹344.83 Cr ₹290.39 Cr ₹213.32 Cr ₹220.88 Cr ₹225.36 Cr ₹251.82 Cr
Exceptional Items -₹45.82 Cr ₹17.65 Cr -₹58.26 Cr ₹0 -₹205.05 Cr ₹0 ₹0 ₹0 -₹136.72 Cr ₹68.01 Cr ₹0 ₹0
Profit Before Tax ₹404.45 Cr ₹445.98 Cr ₹391.58 Cr ₹330.51 Cr ₹128 Cr ₹367.92 Cr ₹344.83 Cr ₹290.39 Cr ₹76.6 Cr ₹288.89 Cr ₹225.36 Cr ₹251.82 Cr
Total Tax Expense ₹95.05 Cr ₹81.93 Cr ₹108.08 Cr ₹96.09 Cr ₹62.22 Cr ₹90.59 Cr ₹99.39 Cr ₹91.41 Cr ₹73.69 Cr ₹66.24 Cr ₹87.92 Cr ₹85.61 Cr
Net Profit ₹306.69 Cr ₹363.67 Cr ₹280.53 Cr ₹232.89 Cr ₹63.99 Cr ₹276.36 Cr ₹245.75 Cr ₹199.14 Cr ₹1.33 Cr ₹221 Cr ₹136.49 Cr ₹164.1 Cr
  attributable to Owners ₹299.07 Cr ₹326.27 Cr ₹282.57 Cr ₹233.21 Cr ₹67.82 Cr ₹248.14 Cr ₹229.48 Cr ₹192.24 Cr ₹59.59 Cr ₹179.88 Cr ₹145.06 Cr ₹162.82 Cr
  attributable to NCI ₹7.62 Cr ₹37.4 Cr -₹2.04 Cr -₹32 Lakh -₹3.83 Cr ₹28.22 Cr ₹16.27 Cr ₹6.9 Cr -₹58.26 Cr ₹41.12 Cr -₹8.57 Cr ₹1.28 Cr
Other Comprehensive Income ₹27.33 Cr -₹60 Lakh ₹11.08 Cr ₹4.95 Cr -₹7.41 Cr -₹12.64 Cr -₹4.88 Cr ₹38 Lakh -₹8.48 Cr ₹1.03 Cr -₹76 Lakh -₹1.24 Cr
Total Comprehensive Income ₹334.02 Cr ₹363.07 Cr ₹291.61 Cr ₹237.84 Cr ₹56.58 Cr ₹263.72 Cr ₹240.87 Cr ₹199.52 Cr -₹7.15 Cr ₹222.03 Cr ₹135.73 Cr ₹162.86 Cr
EBITDA (computed) ₹577.61 Cr ₹553.54 Cr ₹572.78 Cr ₹449.08 Cr ₹454.68 Cr ₹483.19 Cr ₹467.74 Cr ₹413.33 Cr ₹340.82 Cr ₹353.78 Cr ₹359.82 Cr ₹352.47 Cr
Basic EPS ₹11.79 ₹12.86 ₹11.14 ₹9.19 ₹2.67 ₹9.78 ₹9.05 ₹7.58 ₹2.35 ₹7.09 ₹5.72 ₹6.42
Diluted EPS ₹11.79 ₹12.86 ₹11.14 ₹9.19 ₹2.67 ₹9.78 ₹9.05 ₹7.58 ₹2.35 ₹7.09 ₹5.72 ₹6.42
Latest 12 quarters shown of 25 on record.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2020
Revenue from Operations ₹7,336.75 Cr ₹6,677.92 Cr ₹6,166.46 Cr ₹5,814.62 Cr ₹5,399.36 Cr ₹4,367.43 Cr
Other Income ₹94.64 Cr ₹71.29 Cr ₹111.29 Cr ₹111.19 Cr ₹56.13 Cr ₹64.69 Cr
Total Income ₹7,431.39 Cr ₹6,749.21 Cr ₹6,277.75 Cr ₹5,925.81 Cr ₹5,455.49 Cr ₹4,432.12 Cr
Cost of Materials Consumed ₹1,568.33 Cr ₹1,417.64 Cr ₹1,688.36 Cr ₹1,684.03 Cr ₹1,600.98 Cr ₹1,431.1 Cr
Purchases of Stock-in-Trade ₹348.51 Cr ₹347.24 Cr ₹345.21 Cr ₹280.91 Cr ₹282.9 Cr ₹204.65 Cr
Changes in Inventories -₹60.06 Cr ₹128.43 Cr -₹55.19 Cr ₹104.09 Cr -₹120.76 Cr -₹155.05 Cr
Employee Benefit Expense ₹1,655.9 Cr ₹1,479.34 Cr ₹1,336.19 Cr ₹1,193.39 Cr ₹1,089.63 Cr ₹870.79 Cr
Finance Costs ₹43.51 Cr ₹63.04 Cr ₹120.67 Cr ₹43.92 Cr ₹7.21 Cr ₹15.79 Cr
Depreciation & Amortisation ₹268.87 Cr ₹251.97 Cr ₹246.48 Cr ₹228.63 Cr ₹204.1 Cr ₹178.69 Cr
Other Expenses ₹2,043.78 Cr ₹1,780.24 Cr ₹1,640.51 Cr ₹1,640.35 Cr ₹1,303.07 Cr ₹1,101.18 Cr
Total Expenses ₹5,868.84 Cr ₹5,467.9 Cr ₹5,322.23 Cr ₹5,175.32 Cr ₹4,367.13 Cr ₹3,647.15 Cr
Profit Before Exceptional Items & Tax ₹1,562.55 Cr ₹1,281.31 Cr ₹955.52 Cr ₹750.49 Cr ₹1,088.36 Cr ₹784.97 Cr
Exceptional Items -₹30.42 Cr -₹281.54 Cr -₹133.36 Cr ₹0 ₹0 ₹0
Profit Before Tax ₹1,532.13 Cr ₹999.77 Cr ₹822.16 Cr ₹750.49 Cr ₹1,088.36 Cr ₹784.97 Cr
Total Tax Expense ₹399.61 Cr ₹349.01 Cr ₹291.75 Cr ₹244.79 Cr ₹217.42 Cr ₹132.51 Cr
Net Profit ₹1,132.52 Cr ₹650.76 Cr ₹530.41 Cr ₹505.7 Cr ₹870.94 Cr ₹652.46 Cr
Other Comprehensive Income ₹5.95 Cr -₹6.37 Cr -₹8.26 Cr -₹2.68 Cr ₹1.16 Cr -₹7.67 Cr
Total Comprehensive Income ₹1,138.47 Cr ₹644.39 Cr ₹522.15 Cr ₹503.02 Cr ₹872.1 Cr ₹644.79 Cr
EBITDA (computed) ₹1,874.93 Cr ₹1,596.32 Cr ₹1,322.67 Cr ₹1,023.04 Cr ₹1,299.67 Cr ₹979.45 Cr
Basic EPS ₹44.64 ₹25.65 ₹20.91 ₹19.39 ₹34.33 ₹51.64
Diluted EPS ₹44.64 ₹25.65 ₹20.91 ₹19.39 ₹34.33 ₹51.60
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹9,775.5 Cr ₹9,070.92 Cr ₹8,659.27 Cr ₹8,446.97 Cr
Non-current Assets ₹5,780.5 Cr ₹5,252.87 Cr ₹5,149.38 Cr ₹3,571.82 Cr
Current Assets ₹3,995 Cr ₹3,779.94 Cr ₹3,509.89 Cr ₹4,875.15 Cr
Property, Plant & Equipment ₹2,934.82 Cr ₹2,502.78 Cr ₹2,502.09 Cr ₹2,454.58 Cr
Inventories ₹1,707.51 Cr ₹1,542.39 Cr ₹1,677.09 Cr ₹1,660.13 Cr
Trade Receivables ₹1,272.05 Cr ₹1,154.61 Cr ₹1,027.4 Cr ₹925.9 Cr
Cash & Equivalents ₹311.51 Cr ₹76.77 Cr ₹108.27 Cr ₹1,183.7 Cr
Equity (Net Worth) ₹7,979.35 Cr ₹6,891.62 Cr ₹6,348.71 Cr ₹5,877.3 Cr
Equity Share Capital ₹25.37 Cr ₹25.37 Cr ₹25.37 Cr ₹25.37 Cr
Borrowings (Non-current) ₹70 Cr ₹482.43 Cr ₹542.19 Cr ₹651.78 Cr
Borrowings (Current) ₹165.16 Cr ₹389.3 Cr ₹590.72 Cr ₹770.83 Cr
Total Debt (computed) ₹235.16 Cr ₹871.73 Cr ₹1,132.91 Cr ₹1,422.61 Cr
Current Liabilities ₹1,418.75 Cr ₹1,417.6 Cr ₹1,520.17 Cr ₹1,677.78 Cr
Total Liabilities ₹1,796.15 Cr ₹2,179.3 Cr ₹2,310.56 Cr ₹2,569.67 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹1,378.12 Cr ₹1,374.07 Cr ₹830.51 Cr ₹762.29 Cr ₹840.14 Cr
Investing Cash Flow -₹696.99 Cr -₹738.81 Cr -₹1,355.18 Cr -₹709.61 Cr -₹823.89 Cr
Financing Cash Flow -₹745.21 Cr -₹428.44 Cr -₹464.88 Cr ₹506.38 Cr ₹426.1 Cr
Capital Expenditure ₹665.45 Cr ₹602.6 Cr ₹360.22 Cr ₹436.87 Cr ₹446.01 Cr
Free Cash Flow (computed) ₹712.67 Cr ₹771.47 Cr ₹470.29 Cr ₹325.42 Cr ₹394.13 Cr
Dividends Paid ₹50.74 Cr ₹101.48 Cr ₹50.74 Cr ₹101.48 Cr ₹101.45 Cr
Net Change in Cash -₹64.08 Cr ₹206.82 Cr -₹989.55 Cr ₹559.06 Cr ₹442.35 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹1,814.35 Cr ₹1,845.18 Cr ₹1,930.32 Cr ₹1,746.9 Cr ₹1,638.44 Cr ₹1,662.68 Cr ₹1,810.94 Cr ₹1,565.86 Cr ₹1,510.62 Cr ₹1,506.83 Cr ₹1,662.67 Cr ₹1,488.71 Cr
Other Income ₹29.88 Cr ₹17.82 Cr ₹21.92 Cr ₹25.02 Cr ₹21.49 Cr ₹17.41 Cr ₹17 Cr ₹15.39 Cr ₹15.1 Cr ₹16.89 Cr ₹36.14 Cr ₹43.16 Cr
Total Income ₹1,844.23 Cr ₹1,863 Cr ₹1,952.24 Cr ₹1,771.92 Cr ₹1,659.93 Cr ₹1,680.09 Cr ₹1,827.94 Cr ₹1,581.25 Cr ₹1,525.72 Cr ₹1,523.72 Cr ₹1,698.81 Cr ₹1,531.87 Cr
Cost of Materials Consumed ₹406.27 Cr ₹389.15 Cr ₹377.32 Cr ₹395.59 Cr ₹351.67 Cr ₹352.01 Cr ₹378.93 Cr ₹335.03 Cr ₹363.37 Cr ₹411.25 Cr ₹485.72 Cr ₹428.02 Cr
Purchases of Stock-in-Trade ₹85.03 Cr ₹89.97 Cr ₹89.4 Cr ₹84.11 Cr ₹79.06 Cr ₹81.08 Cr ₹94.76 Cr ₹92.34 Cr ₹78.14 Cr ₹75.25 Cr ₹100.13 Cr ₹91.69 Cr
Changes in Inventories -₹35.51 Cr -₹36.67 Cr ₹43.93 Cr -₹31.81 Cr ₹14.79 Cr ₹26.17 Cr ₹62.25 Cr ₹25.22 Cr ₹42.2 Cr -₹1.11 Cr -₹50.96 Cr -₹45.32 Cr
Employee Benefit Expense ₹413.53 Cr ₹421.07 Cr ₹411.39 Cr ₹409.91 Cr ₹377.12 Cr ₹358.48 Cr ₹382.44 Cr ₹361.3 Cr ₹333.22 Cr ₹334.33 Cr ₹336.15 Cr ₹332.49 Cr
Finance Costs ₹10.48 Cr ₹9.51 Cr ₹11.46 Cr ₹12.06 Cr ₹16.2 Cr ₹10.17 Cr ₹17.25 Cr ₹19.42 Cr ₹24.06 Cr ₹27.21 Cr ₹38.64 Cr ₹30.76 Cr
Depreciation & Amortisation ₹70.31 Cr ₹68.57 Cr ₹66.86 Cr ₹63.13 Cr ₹65.19 Cr ₹62.81 Cr ₹62.65 Cr ₹61.32 Cr ₹61.76 Cr ₹63.02 Cr ₹61.35 Cr ₹60.35 Cr
Other Expenses ₹513.85 Cr ₹504.18 Cr ₹543.57 Cr ₹482.18 Cr ₹457.21 Cr ₹433.85 Cr ₹490.45 Cr ₹398.73 Cr ₹401.35 Cr ₹413.62 Cr ₹482.65 Cr ₹384.3 Cr
Total Expenses ₹1,463.96 Cr ₹1,445.78 Cr ₹1,543.93 Cr ₹1,415.17 Cr ₹1,361.24 Cr ₹1,324.57 Cr ₹1,488.73 Cr ₹1,293.36 Cr ₹1,304.1 Cr ₹1,323.57 Cr ₹1,453.68 Cr ₹1,282.29 Cr
Profit Before Exceptional Items & Tax ₹380.27 Cr ₹417.22 Cr ₹408.31 Cr ₹356.75 Cr ₹298.69 Cr ₹355.52 Cr ₹339.21 Cr ₹287.89 Cr ₹221.62 Cr ₹200.15 Cr ₹245.13 Cr ₹249.58 Cr
Exceptional Items -₹30.42 Cr ₹0 ₹0 ₹0 -₹281.54 Cr ₹0 ₹0 ₹0 -₹94.32 Cr ₹0 ₹0 ₹0
Profit Before Tax ₹349.85 Cr ₹417.22 Cr ₹408.31 Cr ₹356.75 Cr ₹17.15 Cr ₹355.52 Cr ₹339.21 Cr ₹287.89 Cr ₹127.3 Cr ₹200.15 Cr ₹245.13 Cr ₹249.58 Cr
Total Tax Expense ₹87.56 Cr ₹113.77 Cr ₹103.57 Cr ₹94.71 Cr ₹82.2 Cr ₹87.96 Cr ₹95.09 Cr ₹83.76 Cr ₹62.54 Cr ₹63.21 Cr ₹83 Cr ₹83 Cr
Net Profit ₹262.29 Cr ₹303.45 Cr ₹304.74 Cr ₹262.04 Cr -₹65.05 Cr ₹267.56 Cr ₹244.12 Cr ₹204.13 Cr ₹64.76 Cr ₹136.94 Cr ₹162.13 Cr ₹166.58 Cr
Other Comprehensive Income ₹5.98 Cr -₹7 Lakh ₹1.93 Cr -₹1.89 Cr ₹2.57 Cr -₹1.31 Cr -₹7.64 Cr ₹1 Lakh -₹6.83 Cr -₹65 Lakh -₹31 Lakh -₹47 Lakh
Total Comprehensive Income ₹268.27 Cr ₹303.38 Cr ₹306.67 Cr ₹260.15 Cr -₹62.48 Cr ₹266.25 Cr ₹236.48 Cr ₹204.14 Cr ₹57.93 Cr ₹136.29 Cr ₹161.82 Cr ₹166.11 Cr
EBITDA (computed) ₹461.06 Cr ₹495.3 Cr ₹486.63 Cr ₹431.94 Cr ₹380.08 Cr ₹428.5 Cr ₹419.11 Cr ₹368.63 Cr ₹307.44 Cr ₹290.38 Cr ₹345.12 Cr ₹340.69 Cr
Basic EPS ₹10.34 ₹11.96 ₹12.01 ₹10.33 ₹-2.56 ₹10.55 ₹9.62 ₹8.05 ₹2.55 ₹5.40 ₹6.39 ₹6.57
Diluted EPS ₹10.34 ₹11.96 ₹12.01 ₹10.33 ₹-2.56 ₹10.55 ₹9.62 ₹8.05 ₹2.55 ₹5.40 ₹6.39 ₹6.57
Latest 12 quarters shown of 24 on record.
Want more history and ratios?
You're viewing the latest exchange-filed financials for Ipca Laboratories Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Ipca Laboratories Limited

As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 44.72%, foreign institutional investors hold 10.63%, domestic institutional investors hold 37.45%, retail and other public shareholders hold 7.20% of Ipca Laboratories Limited. The company had 82,184 shareholders on record.

Promoters: 44.72%DII (Domestic Institutional): 37.45%FII (Foreign Institutional): 10.63%Retail & Others: 7.20%
Mar 2026
QUARTER
44.72% Promoters
37.45% DII (Domestic Institutional)
10.63% FII (Foreign Institutional)
7.20% Retail & Others
Promoter holding - history
Now 44.72% · Mar 2026High 46.30% · Mar 2024Low 44.72% · Dec 2024
43%44.3%45.5%46.8%48%Dec 2015Jun 2018Dec 2020Jun 2023Dec 2025Dec 2015: 45.89%Mar 2016: 45.89%Jun 2016: 45.90%Sep 2016: 46.01%Dec 2016: 46.13%Mar 2017: 46.13%Jun 2017: 46.13%Sep 2017: 46.13%Dec 2017: 46.13%Mar 2018: 46.13%Jun 2018: 46.07%Sep 2018: 46.07%Dec 2018: 46.07%Mar 2019: 46.07%Jun 2019: 46.07%Sep 2019: 46.07%Dec 2019: 46.07%Mar 2020: 46.07%Jun 2020: 46.07%Sep 2020: 46.07%Dec 2020: 46.29%Mar 2021: 46.29%Jun 2021: 46.29%Sep 2021: 46.29%Dec 2021: 46.29%Mar 2022: 46.29%Jun 2022: 46.29%Sep 2022: 46.29%Dec 2022: 46.29%Mar 2023: 46.29%Jun 2023: 46.29%Sep 2023: 46.29%Dec 2023: 46.29%Mar 2024: 46.30%Jun 2024: 46.30%Sep 2024: 46.30%Dec 2024: 44.72%Mar 2025: 44.72%Jun 2025: 44.72%Sep 2025: 44.72%Dec 2025: 44.72%Mar 2026: 44.72%46.30%44.72%44.72%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Promoters44.72%44.72%44.72%44.72%44.72%44.72%
Public55.28%55.28%55.28%55.28%55.28%55.28%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016
Promoters44.72%44.72%46.30%46.29%46.29%46.29%46.07%46.07%46.13%46.13%45.89%
Public55.28%55.28%53.70%53.71%53.71%53.71%53.93%53.93%53.87%53.87%54.11%
Promoter change (YoY, %pts)+0.00-1.58+0.01+0.00+0.00+0.22+0.00-0.06+0.00+0.24-

Board & Governance of Ipca Laboratories Limited

As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Ipca Laboratories Limited has 8 directors - 4 independent and 4 executive. The board is chaired by Premchand Godha.

DirectorPositionOn board sinceListed boards
Premchand Godha Executive Director · Chairperson 1975-10-31 1
A. K. Jain Executive Director · MD 1994-08-21 1
Pranay Godha Executive Director · CEO-MD 2008-11-11 2
Prashant Godha Executive Director 2011-07-28 4
Narendra Mairpady Non-Executive - Independent Director 2022-10-20 5
Kamal Kishore Seth Non-Executive - Independent Director 2019-03-29 2
Swati Patankar Non-Executive - Independent Director 2024-02-14 2
Vivek Keshav Shiralkar Non-Executive - Independent Director 2024-05-29 2
Board Committees
CommitteeMembers
Audit Committee Kamal Kishore Seth (Chairperson), Narendra Mairpady, Prashant Godha, Swati Patankar, Vivek Keshav Shiralkar
Nomination and remuneration committee Narendra Mairpady (Chairperson), Kamal Kishore Seth, Swati Patankar, Vivek Keshav Shiralkar
Stakeholders Relationship Committee Kamal Kishore Seth (Chairperson), Premchand Godha, A. K. Jain, Vivek Keshav Shiralkar
Risk Management Committee Kamal Kishore Seth (Chairperson), A. K. Jain, Pranay Godha, Prashant Godha, Manish Jain
Corporate Social Responsibility Committee Kamal Kishore Seth (Chairperson), Premchand Godha, A. K. Jain, Prashant Godha

Group Structure of Ipca Laboratories Limited

Ipca Laboratories Limited has 3 subsidiary companies, 2 joint ventures, and 3 associated companies. This group structure data is as of FY 2024. The corporate group structure reflects Ipca Laboratories Limited's business expansion strategy and organizational complexity.

3
Subsidiary companies
2
Joint ventures
3
Associated companies
Key Subsidiaries
Company Name CIN Shares Held
Unichem Laboratories Limited L99999MH1962PLC012451 -
Trophic Wellness Private Limited U24100MH2010PTC206526 -
Ipca Foundation U85300MH2021NPL360586 -

Showing major subsidiaries. Total: 3.

Charges & Borrowings of Ipca Laboratories Limited

Open charges
₹2,303.63 Cr
Satisfied charges
₹2,406.67 Cr
Breakdown by lending institutions
Idbi Trusteeship Services Limited₹1,510.00 Cr
Hdfc Bank Limited₹691.22 Cr
Kotak Mahindra Bank Limited₹29.70 Cr
Canara Bank₹28.22 Cr
Icici Banking Corporation Ltd.₹20.00 Cr
Others₹24.49 Cr
Latest charge details
DateLenderAmountStatus
29 Aug 2023 Hdfc Bank Limited ₹300 Cr Open
07 Oct 2022 Hdfc Bank Limited ₹391.22 Cr Open
25 Mar 2022 Others ₹1.9 Cr Open
11 Mar 2022 Others ₹10 Lakh Open
03 May 2013 Idbi Trusteeship Services Limited ₹790 Cr Open

Total charge records: 108 View all charges

Employees and EPFO Compliance at Ipca Laboratories Limited

Ipca Laboratories Limited has a workforce of 17,422 employees as of Feb 28, 2025.

Employee count
17,422
Active EPFO establishments
17
Employee growth
-6.99%
Premium access

Employee and EPFO history for Ipca Laboratories Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Ipca Laboratories Limited

Premium access

GST registrations and filing compliance for Ipca Laboratories Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Ipca Laboratories Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Ipca Laboratories Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Ipca Laboratories Limited

Premium access

MSME payment history for Ipca Laboratories Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Ipca Laboratories Limited

Premium access

Corporate group structure for Ipca Laboratories Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Ipca Laboratories Limited

Premium access

MCA filings and documents for Ipca Laboratories Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Ipca Laboratories Limited

Charges
11 Feb 2026
A charge registered on 24 Jan 2025 via Charge ID 101041701 with Citi Bank N.A. was fully satisfied on 11 Feb 2026.
Charges
09 Jan 2026
A charge registered on 08 Aug 2023 via Charge ID 100768745 with The Hongkong And Shanghai Banking Corporation Limited was fully satisfied on 09 Jan 2026.
Charges
07 Jan 2026
A charge registered on 02 Aug 2022 via Charge ID 100633351 with Jp Morgan Chase Bank, N.A. was fully satisfied on 07 Jan 2026.
Activity
11 Aug 2025
Ipca Laboratories Limited last Annual general meeting of members was held on 11 Aug 2025 as per latest MCA records.
Activity
31 Mar 2025
Ipca Laboratories Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Charges
24 Jan 2025
A charge with Citi Bank N.A. amounted to Rs. 166.60 Cr with Charge ID 101041701 was registered on 24 Jan 2025.

Recent News on Ipca Laboratories Limited

Pharma stocks flout market slump on US tariffs exemption
03 Apr 2025 · Thehindubusinessline
Stocks that will see action today: 13 February, 2025
13 Feb 2025 · Thehindubusinessline

Frequently Asked Questions about Ipca Laboratories Limited

Ipca Laboratories Limited is an active public limited company in the pharma sector based in Kandivali West, Maharashtra, India. It was incorporated on 19 October 1949 (77+ years old) and is registered under CIN L24239MH1949PLC007837. Listed on BSE: 524494 and NSE: IPCALAB. The company has 17,422 employees.

Ipca Laboratories Limited reported revenue of ₹9,646.33 Cr for FY 2026 (up 7.91% YoY) based on consolidated NSE filings.

The current directors of Ipca Laboratories Limited are:

The primary industry of Ipca Laboratories Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Yes. Ipca Laboratories Limited is listed on both BSE (code: 524494) and NSE (symbol: IPCALAB).

Ipca Laboratories Limited can be reached at the registered office: 48 Kandivli Industrial Estate, Kandivli West, Kandivali West, Maharashtra, India – 400067, or through the website ipca.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available